Conferring aldosterone synthesis to human CYP11B1 by replacing key amino acid residues with CYP11B2-specific ones
Open accessAbstract
Performing residue‐swapping experiments between the highly conserved human steroidogenic proteins CYP11B1 and CYP11B2 we recently demonstrated that replacement of specific residues at position 301, 302 and 320 in the aldosterone‐producing CYP11B2 protein for such residues that were specific for the highly similar cortisol‐producing CYP11B1 protein elevated the 11β‐hydroxylase activity dramatically. Conversely, aldosterone synthesis in the triple mutant was severely impaired. Here we provide evidence that in a reciprocal experiment, CYP11B2‐specific amino acids at position 320 and 335 endowed CYP11B1 with an 18‐oxidase function amounting to 20 % of the CYP11B2 wild‐type activity, thus changing the specificity of steroid hydroxylation by only one point mutation. Combining substitutions at positions 296, 301, 302, 320, 335 and 339 did, however, not result in further enhancement. Paradoxically, 11β‐hydroxylation was not or only marginally affected in CYP11B1 mutants, indicating an alternative structural basis for this activity in CYP11B1 compared with the engineered CYP11B2 variant. Our results suggest that the sequence spanned by amino acids 301 and 335 constitutes part of the substrate‐binding site in CYP11B1 and CYP11B2 as well. By constructing chimeric proteins we further investigated the effect of the C‐terminal portions of both proteins and found that diverging residues at positions 471, 472, 492, 493 and 494 were insignificant for the stereospecificity and regiospecificity of steroid hydroxylation.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Residues 288, 296, 301, 302, 325, and, perhaps most importantly, 320 are critical for 18-oxygenase activity.
“Residues 288, 296, 301, 302, 325, and, perhaps most importantly, 320 are critical (496, 497).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [496]
The Discussion (page unavailable) reports that substitutions at position 320 produced 18-oxidation activity and discusses a possible role for residue 288. It tested positions 296, 301, and 302, but does not establish each as critical for 18-oxidation; the other position it identifies with 18-oxidation activity is 335, not the claimed 325. (LLM, conf=0.87)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Still being checked.
Research works printed but not linked: 8
- [1]1. ylase/aldosterone synthase gene causes glucocorticoid-remediable tion, as compared with the comparatively weakly transcribed aldosteronism and human hypertension, Nature 355, 262Ϫ265. CYP11B2 gene, also mutant CYP11B1 proteins only moderately 18. Pascoe, L., Curnow, K. M., Slutsker, L., Connell, J. M., Speiser, P. synthesizing aldosterone could drastically elevate circulating W., New, M. I. & White, P. C. (1992) Glucocorticoid-suppressible aldosterone levels and thus contribute to high-blood-pressure hyperaldosteronism results from hybrid genes created by unequal phenotypes in subjects carrying such hypothetical mutations. crossovers between CYP11B1 and CYP11B2, Proc. Natl Acad. Sci. USA 89, 8327Ϫ8331. This work was supported by a Grant Be 1343/2-4 from the Deutsche
- [5]5. Miller, W. L. & Tyrell, J. B. (1995) The adrenal cortex, in Endocri- ence 26, 1731Ϫ1736. nology and metabolism (Felig, P., Baxter, J. & Frohman, L., eds) 22. Hasemann, C. A., Ravichandran, K. G., Peterson, J. A. & Deisen- pp. 555Ϫ711, McGraw Hill, New York.
- [7]7. brook, R. W., Feyereisen, R., Gonzalez, F. J., Coon, M. J., Gunsa- 23. Cupp-Vickery, J. R. & Poulos, T. L. (1995) Structure of cytochrome lus, I. C., Gotoh, O., Okuda, K. & Nebert, D. W. (1993) The P450 P450eryF involved in erythromycin biosynthesis, Nat. Struct. superfamily: update on new sequences, gene mapping, accession Biol. 2, 144Ϫ153. numbers, early trivial names of enzymes, and nomenclature, DNA 24. Böttner, B. & Bernhardt, R. (1996) Changed ratios of glucocorti- Cell. Biol. 12, 1Ϫ51. coids/mineralocorticoids caused by point mutations in the putative 3. Chua, S. C., Szabo, P., Vitek, A., Grzeschik, K. H., John, M. & I-helix regions of CYP11B1 and CYP11B2, Endocr. Res. 22, White, P. C. (1987) Cloning of cDNA encoding steroid 11 beta- 455Ϫ461. hydroxylase (P450c11), Proc. Natl Acad. Sci. USA 84, 7193Ϫ 25. Brizzard, B. L., Chubet, R. G. & Vizard, D. L. (1994) Immunoaffin- 7197. ity purification of FLAG epitope-tagged bacterial alkaline phos- 4.
- [11]11. Sanger, F., Nicklen, S. & Coulson, A. R. (1977) DNA sequencing 6. Kawamoto, T., Mitsuuchi, Y., Toda, K., Miyahara, K., Yokoyama, with chain-terminating inhibitors, Proc. Natl Acad. Sci. USA 74, Y., Nakao, K., Hosoda, K., Yamamoto, Y., Imura, H. & Shizuta, 5463Ϫ5467. Y. (1990) Cloning of cDNA and genomic DNA for human cyto- 28.
- [15]15. Zuber, M. X., Mason, J. I., Simpson, E. R. & Waterman, M. R. doxin reductase. Identification of NADP-binding sites in oxidore- (1988) Simultaneous transfection of COS-1 cells with mito- ductases, Eur. J. Biochem. 180, 479Ϫ484. chondrial and microsomal steroid hydroxylases: incorporation of 9. Lambeth, J. D., Seybert, D. W. & Kamin, H. (1979) Ionic effects a steroidogenic pathway into nonsteroidogenic cells, Proc. Natl on adrenal steroidogenic electron transport. The role of adreno- Acad. Sci. USA 85, 699Ϫ703.
- [18]18. Juvonen, R. O., Iwasaki, M. & Negishi, M. (1991) Structural func- mosome 17cenϪq25 are expressed in steroidogenic tissues, Proc. tion of residue-209 in coumarin 7-hydroxylase (P450coh). En- Natl Acad. Sci. USA 85, 7104Ϫ7108. zyme-kinetic studies and site-directed mutagenesis, J. Biol. Chem.
- [27]27. Lifton, R. P., Dluhy, R. G., Powers, M., Rich, G. M., Cook, S., 37. Gotoh, O. (1992) Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of Ulick, S. & Lalouel, J. M. (1992) A chimaeric 11 beta-hydrox- amino acid and coding nucleotide sequences, J. Biol. Chem. 267, role of the hydroxy amino acid in oxygen activation, Proc. Natl Acad. Sci. USA 86, 7823Ϫ7827. 83Ϫ90.
- [33]33. Harikrishna, J. A., Black, S. M., Szklarz, G. D. & Miller, W. L. (1993) Construction and function of fusion enzymes of the human coupling of the cytochrome P-450cam monooxygenase reaction by a single mutation, threonine-252 to alanine or valine: possible cytochrome P450scc system, DNA Cell Biol. 12, 371Ϫ379. 14321033, 1998, 3, Downloaded from https://febs.onlinelibrary.wiley.com/doi/10.1046/j.1432-1327.1998.2520458.x, Wiley Online Library on [28/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
Cited by
Sorted by citations
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458 · see citing works
Cytochromes P450 as versatile biocatalysts
Bernhardt, R. (2006) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2006.01.026 · Cited by 888 · see citing works
Self-citationHuman cytochromes P450 in health and disease
Nebert, D. W., Wikvall, K., & Miller, W. L. (2013) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2012.0431 · Cited by 505 · see citing works
Guengerich, F. P. (2007) · Springer eBooks · doi:10.1007/0-387-27447-2_10 · Cited by 220 · see citing works
Guengerich, F. P. (2015) · Springer eBooks · doi:10.1007/978-3-319-12108-6_9 · Cited by 150 · see citing works
STEROID 11β-HYDROXYLASE DEFICIENCY AND RELATED DISORDERS
White, P. C. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(08)70019-7 · Cited by 144 · see citing works
Structural Insights into Aldosterone Synthase Substrate Specificity and Targeted Inhibition
Strushkevich, N. V., Gilep, A. A., Shen, L., Arrowsmith, C. H., Edwards, A. M., Usanov, S. A., & Park, H. (2013) · Molecular Endocrinology · doi:10.1210/me.2012-1287 · Cited by 136 · see citing works
Modulation of aldosterone and cortisol synthesis on the molecular level
Lisurek, M., & Bernhardt, R. (2004) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.11.008 · Cited by 98 · see citing works
Self-citationSchalk, M., & Croteau, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.22.11948 · Cited by 97 · see citing works
CYP17- and CYP11B-dependent steroid hydroxylases as drug development targets
Hakki, T., & Bernhardt, R. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.07.006 · Cited by 91 · see citing works
Self-citationMulatero, P., Curnow, K. M., Aupetit-Faisant, B., Foekling, M., Gomez-Sanchez, C., Veglio, F., Jeunemaitre, X., Corvol, P., & Pascoe, L. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.11.5237 · Cited by 88 · see citing works
The Human Steroid Hydroxylases CYP11B1 and CYP11B2
Bureik, M., Lisurek, M., & Bernhardt, R. (2002) · Biological Chemistry · doi:10.1515/bc.2002.174 · Cited by 88 · see citing works
Self-citationLucas, S., Heim, R., Ries, C., Schewe, K. E., Birk, B., & Hartmann, R. W. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800888q · Cited by 78 · see citing works
Lucas, S., Heim, R., Negri, M., Antes, I., Ries, C., Schewe, K. E., Bisi, A., Gobbi, S., & Hartmann, R. W. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800683c · Cited by 72 · see citing works
Lucas, S., Negri, M., Heim, R., Zimmer, C., & Hartmann, R. W. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101470k · Cited by 71 · see citing works
Mendieta, M. A. E. P., Negri, M., Jagusch, C., Müller‐Vieira, U., Lauterbach, T., & Hartmann, R. W. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800355c · Cited by 69 · see citing works
Construction of 3D models of the CYP11B family as a tool to predict ligand binding characteristics
Roumen, L., Sanders, M. P. A., Pieterse, K., Hilbers, P. A. J., Plate, R., Custers, E. M. G., de Gooyer, M. E., Smits, J. F. M., Beugels, I. P. E., Emmen, J. M. A., et al. (2007) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-007-9128-9 · Cited by 64 · see citing works
Efficient conversion of 11-deoxycortisol to cortisol (hydrocortisone) by recombinant fission yeast
Dragan, C.-A., Zearo, S., Hannemann, F., Bernhardt, R., & Bureik, M. (2004) · FEMS Yeast Research · doi:10.1016/j.femsyr.2004.12.001 · Cited by 62 · see citing works
Self-citationHu, Q., Negri, M., Jahn‐Hoffmann, K., Zhuang, Y., Ölgen, S., Bartels, M., Müller‐Vieira, U., Lauterbach, T., & Hartmann, R. W. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.07.011 · Cited by 60 · see citing works
Changing the Regioselectivity of a P450 from C15 to C11 Hydroxylation of Progesterone
Nguyen, K. T., Virus, C., Günnewich, N., Hannemann, F., & Bernhardt, R. (2012) · ChemBioChem · doi:10.1002/cbic.201100811 · Cited by 59 · see citing works
Self-citationKrone, N. P., Riepe, F. G., Götze, D., Korsch, E., Rister, M., Commentz, J., Partsch, C., Grötzinger, J., Peter, M., & Sippell, W. G. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0089 · Cited by 58 · see citing works
Hampf, M., Dao, N. T. N., Hoàn, N. T., & Bernhardt, R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7820 · Cited by 63 · see citing works
Self-citationThe 25(OH)D3/1α,25(OH)2D3-24R-hydroxylase: a catabolic or biosynthetic enzyme?
Henry, H. L. (2001) · Steroids · doi:10.1016/s0039-128x(00)00158-6 · Cited by 54 · see citing works
Heim, R., Lucas, S., Grombein, C. M., Ries, C., Schewe, K. E., Negri, M., Birk, B., & Hartmann, R. W. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800377h · Cited by 49 · see citing works
Brixius‐Anderko, S., & Scott, E. E. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006214 · Cited by 49 · see citing works
Engineering and assaying of cytochrome P450 biocatalysts
Rabe, K. S., Gandubert, V. J., Spengler, M., Erkelenz, M., & Niemeyer, C. M. (2008) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-008-2248-9 · Cited by 47 · see citing works
Inhibition of Cytochromes P450: Existing and New Promising Therapeutic Targets
Schuster, I., & Bernhardt, R. (2007) · Drug Metabolism Reviews · doi:10.1080/03602530701498455 · Cited by 44 · see citing works
Self-citationKrone, N. P., Grischuk, Y., Müller, M., Volk, R. E., Grötzinger, J., Holterhus, P., Sippell, W. G., & Riepe, F. G. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0209 · Cited by 43 · see citing works
Roumen, L., Peeters, J. W., Emmen, J. M. A., Beugels, I. P. E., Custers, E. M. G., de Gooyer, M. E., Plate, R., Pieterse, K., Hilbers, P. A. J., Smits, J. F. M., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901356d · Cited by 41 · see citing works
Hakki, T., Zearo, S., Drăgan, C.-A., Bureik, M., & Bernhardt, R. (2007) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2007.06.022 · Cited by 41 · see citing works
Self-citationLisurek, M., Simgen, B., Antes, I., & Bernhardt, R. (2008) · ChemBioChem · doi:10.1002/cbic.200700670 · Cited by 38 · see citing works
Self-citationCao, P., Bülow, H., Dumas, B., & Bernhardt, R. (2000) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(99)00243-5 · Cited by 29 · see citing works
Self-citationLiu, W., Li, Z., Chu, S., Ma, X., Wang, X., Jiang, M., & Bai, G. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.09.013 · Cited by 27 · see citing works
Peng, H., & Auchus, R. J. (2017) · Biochemistry · doi:10.1021/acs.biochem.7b00034 · Cited by 26 · see citing works
Cao, P., & Bernhardt, R. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00704.x · Cited by 26 · see citing works
Self-citationPilon, C., Mulatero, P., Barzon, L., Veglio, F., Garrone, C., Boscaro, M., Sonino, N., & Fallo, F. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.11.6125 · Cited by 28 · see citing works
Bechtel, S., Belkina, N., & Bernhardt, R. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.02729.x · Cited by 26 · see citing works
Self-citationNguyen, H.-H., Hannemann, F., Hartmann, M. F., Małunowicz, E., Wudy, S. A., & Bernhardt, R. (2010) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2010.04.016 · Cited by 25 · see citing works
Self-citationHille, U. E., Hu, Q., Mendieta, M. A. E. P., Bartels, M., Vock, C. A., Lauterbach, T., & Hartmann, R. W. (2009) · Comptes Rendus Chimie · doi:10.1016/j.crci.2009.03.007 · Cited by 23 · see citing works
A Compound Heterozygote Case of Type II Aldosterone Synthase Deficiency
Dunlop, F., Crock, P., Montalto, J., Funder, J. W., & Curnow, K. M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030353 · Cited by 23 · see citing works
Aldosterone synthase deficiency caused by a homozygous L451F mutation in the CYP11B2 gene
Nguyen, H.-H., Hannemann, F., Hartmann, M. F., Wudy, S. A., & Bernhardt, R. (2008) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2007.11.009 · Cited by 22 · see citing works
Self-citationVecchiola, A., Lagos, C. F., Fuentes, C., Allende, F. A., Campino, C., Valdivia, C. P., Tapia-Castillo, A., Ogishima, T., Mukai, K., Owen, G. I., et al. (2013) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-11-76 · Cited by 23 · see citing works
Bernhardt, R. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.03.005 · Cited by 16 · see citing works
Self-citationSpecies differences in 3-methylsulphonyl-DDE bioactivation by adrenocortical tissue
Lindström, V., Brandt, I., & Lindhe, Ö. (2007) · Archives of Toxicology · doi:10.1007/s00204-007-0264-8 · Cited by 15 · see citing works
Mutation analysis of CYP11B1 and CYP11B2 in patients with increased 18-hydroxycortisol production
Nicod, J., Dick, B., Frey, F. J., & Ferrari, P. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.10.056 · Cited by 13 · see citing works
Aldosterone: From biosynthesis to non-genomic action onto the proteome
Zöllner, S. K., HWANG, K., Wilzewski, B., Carapito, C., Leize‐Wagner, E., Van-Dorsselaer, A., & Bernhardt, R. (2008) · Steroids · doi:10.1016/j.steroids.2007.12.029 · Cited by 9 · see citing works
Self-citationBaker, J. E., Plaska, S. W., Qin, Z., Liu, C., Rege, J., Rainey, W. E., & Udager, A. M. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111296 · Cited by 9 · see citing works
Roy, P. P., & Roy, K. (2009) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756360903179476 · Cited by 8 · see citing works
Kinetics of Intermediate Release Enhances P450 11B2-Catalyzed Aldosterone Synthesis
Valentín-Goyco, J., Im, S., & Auchus, R. J. (2024) · Biochemistry · doi:10.1021/acs.biochem.3c00725 · Cited by 5 · see citing works
The Principles, Enzymes, and Pathways of Human Steroidogenesis
Auchus, R. J., & Miller, W. L. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00096-4 · Cited by 5 · see citing works
Mukai, K., Sugimoto, H., Kamiya, K., Suzuki, R., Matsuura, T., Hishiki, T., Shimada, H., Shiro, Y., Suematsu, M., & Kagawa, N. (2021) · Current Research in Structural Biology · doi:10.1016/j.crstbi.2021.08.001 · Cited by 4 · see citing works
Steroid 11β-Hydroxylase Deficiency and Related Disorders
White, P. C. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-416006-4.00006-5 · Cited by 4 · see citing works
Deficiência da 11beta-hidroxilase
de Mello, M. P., Penachioni, J. Y., do Amaral, F. C., & de Castro, M. (2004) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302004000500018 · Cited by 4 · see citing works
Lindhe, Ö. (2001) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 4 · see citing works
Steroid 11β-hydroxylase deficiency and related disorders
White, P. C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821424-4.00010-1 · Cited by 3 · see citing works
Bernhardt, R. (2014) · Springer eBooks · doi:10.1007/978-4-431-54992-5_8 · Cited by 3 · see citing works
Self-citationMiscellaneous endocrine causes of hypertension
Auchus, R. J. (2005) · Current Cardiology Reports · doi:10.1007/s11886-005-0059-6 · Cited by 2 · see citing works
The Principles, Enzymes, and Pathways of Human Steroidogenesis
Auchus, R. J., & Miller, W. L. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00097-4 · Cited by 2 · see citing works
Chimeric Genes Causing 11β-Hydroxylase Deficiency: Implications in Clinical and Molecular Diagnosis
Concolino, P. (2024) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-024-00697-y · Cited by 1 · see citing works
Kleine, B., & Rossmanith, W. G. (2020) · Springer eBooks · doi:10.1007/978-3-662-58502-3_6 · Cited by 1 · see citing works
Molecular genetic investigations of patients with defects in steroid hormone production
Nguyen, H.-H. (2008) · Publications of the UdS (Saarland University) · doi:10.22028/d291-22508
Hormones from Mevalonate: Juvenile Hormone and Steroid Hormones
Kleine, B., & Rossmanith, W. G. (2016) · Springer eBooks · doi:10.1007/978-3-319-15060-4_6
BindingDB (2010) · UC San Diego · doi:10.7270/q2222tk7
- Authors
- Böttner, B., Denner, K., & Bernhardt, R.
- Affiliations
- Max Delbrück Center (DE)
- ORCID
- Bernhardt, Rita
- Venue
- European Journal of Biochemistry
- Publisher
- Wiley
- Published
- 1998-03-15
- Volume
- 252
- Issue
- 3
- Pages
- 458-466
- ISSN
- 0014-2956 (ISSN-L)
- 1432-1033
- OpenAlex
- W2028238691
- Semantic Scholar
- a9be478e98474ed7f4fd963e1952b904296c8a05
- Cited by
- 62
- References
- 0
- Citations by year
- 2024: 2 · 2023: 1 · 2021: 3 · 2020: 1 · 2018: 1 · 2017: 1 · 2016: 1 · 2015: 2 · 2014: 1 · 2013: 4 · 2012: 1
- FWCI
- 2.01
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Journal of Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Steroid Chemistry and Biochemistry
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- CYP11B1, CYP11B2, aldosterone biosynthesis, substrate binding site, fusion protein, steroidogenic enzymes, regiospecificity
- MeSH terms
- Aldosterone, Amino Acid Sequence, Animals, Binding Sites, Humans, Hydroxylation, Molecular Sequence Data, Recombinant Fusion Proteins, Steroid 11-beta-Hydroxylase, Transfection, Mutagenesis, Site-Directed, Sequence Alignment, Sequence Deletion, Sequence Homology, Amino Acid, Protein Structure, Secondary, DNA Primers, Cytochrome P-450 CYP11B2, COS Cells, Amino Acid Substitution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review